Latest DEF 14A proxy statements

eHealth, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect directors, ratify auditor appointment, and approve an equity incentive plan amendment.

Janux Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Puma Biotechnology, Inc. has announced its 2026 annual meeting of stockholders, scheduled for June 11, 2026, to elect directors, ratify auditors, and vote on executive compensation and an extension of CEO Alan H. Auerbach's warrant.

Rocky Brands announces its annual shareholder meeting on June 3, 2026, to elect directors, vote on executive compensation, and ratify auditors.

Context Therapeutics Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 24, 2026, and is seeking approval to increase its authorized common stock.

Akebia Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for June 17, 2026, and proposes a significant increase in authorized common stock.

Jade Biosciences, Inc. has issued its proxy statement, inviting stockholders to its 2026 Annual Meeting of Stockholders on June 9, 2026, to vote on director elections, auditor ratification, and a charter amendment.

Inogen, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 5th, proposing key governance changes including the declassification of its Board of Directors.

Nautilus Biotechnology, Inc. has issued its definitive proxy statement, announcing its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Tarsus Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 25, 2026, with key proposals including director elections and executive compensation.

Fennec Pharmaceuticals Inc. has issued its proxy statement for the Annual and Special Meeting of Shareholders scheduled for June 10, 2026, detailing proposals for director elections, auditor appointments, executive compensation votes, and equity plan amendments.

Graphic Packaging Holding Company has issued its 2026 Proxy Statement, detailing proposals for the upcoming virtual Annual Meeting of Stockholders on June 11, 2026, including director elections, executive compensation, and corporate governance amendments.

BridgeBio Oncology Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors and ratify auditor appointments.

WM Technology, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 24, 2026, to vote on key corporate governance changes including the declassification of its Board of Directors.

Clover Health Investments, Corp. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders, detailing director elections, executive compensation, and auditor ratification.

Ironwood Pharmaceuticals, Inc. has issued its proxy statement detailing the agenda for its 2026 Annual Meeting of Stockholders, including director elections, executive compensation votes, and equity plan amendments.

FinWise Bancorp is holding its 2026 Annual Meeting of Shareholders on June 25, 2026, to elect directors, approve a stock plan amendment, and ratify auditor appointment.

4D Molecular Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for June 17, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

Faraday Future Intelligent Electric Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for May 22, 2026, to vote on several critical proposals including director elections, stock issuances, incentive plan amendments, share authorization, and a potential reverse stock split.

Alector, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 17, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

PepGen Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect directors and ratify auditors.

Bolt Biotherapeutics announces its 2026 Annual Meeting of Stockholders, to be held virtually on June 10, 2026, with key proposals including director elections and auditor ratification.

Visteon Corporation has issued its 2026 Proxy Statement, detailing proposals for the upcoming Annual Meeting of Stockholders, including director elections, auditor ratification, and advisory approval of executive compensation.

ORIC Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to be held virtually, with key proposals including director elections, auditor ratification, and equity plan approval.

InTest Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, stock incentive plan amendments, auditor ratification, and executive compensation.

Dar Bioscience, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to elect directors, ratify auditor appointment, and vote on key corporate proposals including stock issuance and equity plan amendments.

Strategy Inc. is holding its 2026 Annual Meeting of Stockholders on June 8, 2026, via live webcast, to vote on director elections, auditor ratification, executive compensation, and amendments to preferred stock designations.

SIGA Technologies, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to vote on director elections, auditor ratification, executive compensation, and stock incentive plan amendments.

Oxbridge Re Holdings Limited announces its Annual General Meeting on June 12, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Bowman Consulting Group Ltd. has issued its proxy statement for the May 28, 2026 annual meeting, detailing director elections, auditor ratification, and executive compensation.